移植は自然界の成功の証です.

Anti-gonadotropin releasing hormone vaccines and their potential use in the treatment of hormone-responsive cancers.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007

Complex nature of the human antisperm antibody response in SCID mice.

Andrologia·2004

Immunoneutralisation of GnRH-I, without cross-reactivity to GnRH-II, in the development of a highly specific anti-fertility vaccine for clinical and veterinary use.

Journal of reproductive immunology·2001

Characterization of monoclonal antibodies with specificity for the core oligosaccharide of Shigella lipopolysaccharide.

Hybridoma·2001

The evolution of immunoassay technology.

Parasitology·2000

Cardiac myofibrillar proteins: biochemical markers to estimate myocardial injury.

Molecular and cellular biochemistry·1999

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

F/HN-pseudotyped lentiviral vector efficiently transduces non-human primate airways with no evidence of relevant toxicity.

Molecular therapy. Advances·2026

Synergistic Wnt/BMP Co-activation accelerates osteogenic differentiation of human pluripotent stem cells via paraxial mesoderm induction.

Journal of tissue engineering·2026

Recent Advances in Mechanobiology-Mediated In Situ Tissue Engineering.

International journal of biomaterials·2026

Feasibility of acromial periosteal flap technique for enhanced reconstruction of acromioclavicular joint dislocations: a cadaveric study.

Journal of orthopaedic surgery and research·2026

Trophoblast cells rewire the epigenetic landscape of vascular smooth muscle cells to modulate plasticity: a regulatory axis disrupted in intrauterine growth restriction.

Cell communication and signaling : CCS·2026

Recent Trends in Tissue Engineering Strategies for Uterine Endometrial Regeneration: a Systematic Review.

Reproductive sciences (Thousand Oaks, Calif.)·2026

関連する実験動画

移植は自然界の成功の証です.

関連する概念動画

Anti-gonadotropin releasing hormone vaccines and their potential use in the treatment of hormone-responsive cancers.

Complex nature of the human antisperm antibody response in SCID mice.

Immunoneutralisation of GnRH-I, without cross-reactivity to GnRH-II, in the development of a highly specific anti-fertility vaccine for clinical and veterinary use.

Characterization of monoclonal antibodies with specificity for the core oligosaccharide of Shigella lipopolysaccharide.

The evolution of immunoassay technology.

Cardiac myofibrillar proteins: biochemical markers to estimate myocardial injury.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

F/HN-pseudotyped lentiviral vector efficiently transduces non-human primate airways with no evidence of relevant toxicity.

Synergistic Wnt/BMP Co-activation accelerates osteogenic differentiation of human pluripotent stem cells via paraxial mesoderm induction.

Recent Advances in Mechanobiology-Mediated In Situ Tissue Engineering.

Feasibility of acromial periosteal flap technique for enhanced reconstruction of acromioclavicular joint dislocations: a cadaveric study.

Trophoblast cells rewire the epigenetic landscape of vascular smooth muscle cells to modulate plasticity: a regulatory axis disrupted in intrauterine growth restriction.

Recent Trends in Tissue Engineering Strategies for Uterine Endometrial Regeneration: a Systematic Review.

関連する実験動画

移植は自然界の成功の証です.

関連する概念動画

関連記事